ESMO/LinkedIn
Mar 20, 2025, 08:37
Real-world data shaping the future of sarcoma research – ESMO
ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“ESMO Rare Cancers25: Jean-Yves Blay discusses how the use of Real World Data has evolved to fill information gaps in sarcoma research, which have arisen due to the rarity and heterogeneity of subtypes and a lack of trial data.
Now more trusted by regulators, the role of real-world data may grow even further if challenges are addressed including ensuring accurate sarcoma diagnosis, improving access to reference centres and guideline-directed treatments, and standardising data collection.
To learn more, read his Editorial in the ESMO Daily Reporter.”
More posts featuring ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 20, 2025, 17:47
Mar 20, 2025, 17:37
Mar 20, 2025, 17:29
Mar 20, 2025, 16:59
Mar 20, 2025, 15:17